Biosimilar drugs can reduce costs but still face challenges in the US
Biologics used to treat patients can be incredibly expensive, so there was significant hope that biosimilar drugs—which are highly similar to an existing biologic drug on the market—could serve as a less-costly substitute. ...
Nov 4, 2019
0
7